Erythropoietin stimulating agents in the management of anemia of chronic kidney disease

References

• BaranyH-JMuller2007Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney diseaseNephrol Dial Transplant22Suppl 4iv10iv1817526545
   PubMedGoogle Scholar
• BrugnaraC2003Iron deficiency and erythropoiesis: new diagnostic approachesClin Chem491573814500582
   PubMed Web of Science ®Google Scholar
• CollinsAJMaJZEbbenJ2000Impact of hematocrit on morbidity and mortalitySemin Nephrol2034510928336
   PubMed Web of Science ®Google Scholar
• CoyneDWKapoianTSukiW2007Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the dialysis patients’ response to IV iron with elevated ferritin (DRIVE) studyJ Am Soc Nephrol1897517267740
   PubMed Web of Science ®Google Scholar
• DruekeTBLocatelliFClyneN2006Normalization of hemoglobin level in patients with chronic kidney disease and anemiaN Engl J Med35520718417108342
   PubMed Web of Science ®Google Scholar
• EschbachJWKellyMRHaleyNR1989Treatment of the anemia of progressive renal failure with recombinant human erythropoietinN Engl J Med20158632747747
   PubMed Web of Science ®Google Scholar
• FishbaneSFreiGLMaesakaJ1995Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementationAm J Kidney Dis264167611266
   PubMed Web of Science ®Google Scholar
• FoleyRN2006Do we know the correct hemoglobin target for anemic patients with chronic kidney disease?Clin J Am Soc Nephrol16788417699272
   PubMed Web of Science ®Google Scholar
• Information for Healthcare ProfessionalsErythropoiesis Stimulating Agents (ESA) [Aranesp (darbepoetin), Epogen (epoetin alfa), and Procrit (epoetin alfa) [online]Accessed July 17, 2008 URL: http://www.fda.gov/cder/drug/InfoSheets/HCP/RHE2007HCP.htm
   Google Scholar
• JurkovitzCTAbramsonJLVaccarinoLV2003Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) studyJ Am Soc Nephrol14291914569102
   PubMed Web of Science ®Google Scholar
• KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease2007Update of hemoglobin targetAm J Kidney Dis5047153017720528
   PubMed Web of Science ®Google Scholar
• KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease2006Am J Kidney Dis47S1114516678659
   PubMed Web of Science ®Google Scholar
• Le MeurYLorgeotVComteL2001Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: relationship with erythropoietin requirementsAm J Kidney Dis38510711532682
   PubMed Web of Science ®Google Scholar
• LeveyASCoreshJBalkE2003National Kidney Foundation Disease Outcomes Quality Initiative Clinic Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and StratificationAnn Intern Med1391374712859163
   PubMed Web of Science ®Google Scholar
• MaJZEbbenJXiaHCollinsAJ1999Hematocrit level and associated mortality in hemodialysis patientsJ Am Soc Nephrol1061010073612
   PubMed Web of Science ®Google Scholar
• MacdougallIC2008Novel erythropoiesis-stimulating agents: a new era in anemia managementClin J Am Soc Nephrol3200718077782
   PubMed Web of Science ®Google Scholar
• MaeThamerYiZhangJamesKaufman2007Dialysis Facility Ownership and Epoetin Dosing in Patients Receiving HemodialysisJAMA29716677417440144
   PubMed Web of Science ®Google Scholar
• MaxwellPHOsmondMKPughCW1993Identification of the renal erythropoietin-producing cells using transgenic miceKidney Int4411498264149
   PubMed Web of Science ®Google Scholar
• McClellanWAronoffSLBoltonWK2004The prevalence of anemia in patients with chronic kidney diseaseCurr Med Res Opin2015011015383200
   PubMed Web of Science ®Google Scholar
• McClellanWMFlandersWDLangstonRD2002Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based studyJ Am Soc Nephrol13192812089390
   PubMed Web of Science ®Google Scholar
• McFarlaneSISalifuMOMakaryusJ2006Anemia and cardiovascular disease in diabetic nephropathyCurr Diab Rep6213816898574
   PubMedGoogle Scholar
• MohanramAZhangZShahinfarS2008The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetesKidney Int73630618094675
   PubMed Web of Science ®Google Scholar
• OrtegaORodriguezIGallarP2002Significance of high C-reactive protein levels in pre-dialysis patientsNephrol Dial Transplant171105912032204
   PubMed Web of Science ®Google Scholar
• PollockCJohnsonDWHörlWH2008Pure red cell aplasia induced by erythropoiesis-stimulating agentsClin J Am Soc Nephrol3193918178785
   PubMed Web of Science ®Google Scholar
• Public Health Advisory: Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp) [online]Accessed July 17, 2008 URL:http://www.fda.gov/cder/drug/advisory/RHE.htm
   Google Scholar
• RatcliffePJEbertBLFergusonDJ1995Regulation of the erythropoietin geneNephrol Dial Transplant10Suppl 2187644101
   PubMed Web of Science ®Google Scholar
• RighettiMFerrarioGMMilaniS2004A single centre study about the effects of HFR on anemiaG Ital Nefrol21Suppl 30S1687115750978
   PubMedGoogle Scholar
• SinghAKSzczechLTangKL2006Correction of anemia with epoetin alfa in chronic kidney diseaseN Engl J Med35520859817108343
   PubMed Web of Science ®Google Scholar
• TonelliMBlakePGMuirheadN2001Predictors of erythropoietin responsiveness in chronic hemodialysis patientsASAIO J4782511199321
   PubMed Web of Science ®Google Scholar
• TonelliMWinkelmayerWCJindalKK2003The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patientsKidney Int6429530412787422
   PubMed Web of Science ®Google Scholar
• TsirpanlisGBagosPIoannouD2004Exploring inflammation in hemodialysis patients: persistent and superimposed inflammation. A longitudinal studyKidney Blood Press Res27637014691348
   PubMed Web of Science ®Google Scholar
• US Renal Data System, USRDS2005Annual Data Report: Atlas of End-Stage Renal Disease in the United StatesNational Institutes of Health, National Institute of Diabetes and Digestive and Kidney DiseasesBethesda, MD
   Google Scholar
• WannerCRichardsonDFouqueD2007OPTA – Influence of inflammation/infection on anaemia therapy in haemodialysis patientsNephrol Dial Transplant22Suppl 3iii7iii1210.1093/ndt/gfm015
   Web of Science ®Google Scholar
• WishJB2006Assessing iron status: beyond serum ferritin and transferrin saturationClin J Am Soc Nephrol1S4S817699374
   PubMed Web of Science ®Google Scholar
• World Health OrganizationNutritional Anaemias1968Report of a WHO Scientific GroupGeneva, SwitzerlandWorld Health Organization
   Google Scholar